Paper8909668
Alveolar overdistension is an important mechanism of persistent lung damage following severe protracted ARDS.
Finfer S and 1 other. Anaesth Intensive Care, 1996. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Alveolar overdistension is an important mechanism of persistent lung damage following severe protracted ARDS. Papers, record 8909668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8909668
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Alveolar overdistension is an important mechanism of persistent lung damage following severe protracted ARDS.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Lung | Major topic |
| Pulmonary Alveoli | Major topic |
| Respiratory Distress Syndrome | Major topic |
| Adolescent | |
| Adult | |
| Bacterial Infections | |
| Barotrauma | |
| Bronchiectasis | |
| Cysts | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Hydropneumothorax | |
| Ischemia | |
| Lung Diseases | |
| Male | |
| Pleural Diseases | |
| Pleural Effusion | |
| Pneumothorax | |
| Pulmonary Atelectasis | |
| Radiographic Image Enhancement | |
| Respiration, Artificial | |
| Retrospective Studies | |
| Stress, Mechanical | |
| Tidal Volume | |
| Tomography, X-Ray Computed |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38322185 | Pneumomediastinum and pneumothorax in acute respiratory distress syndrome (ARDS) patients: a narrative review. | Mediastinum | 2024 | https://conductscience.org/library/papers/38322185 | PubMed |
| 36950541 | Clinical review of high-flow nasal oxygen therapy in human and veterinary patients. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/36950541 | PubMed |
| 35329965 | Bedside Selection of Positive End Expiratory Pressure by Electrical Impedance Tomography in Patients Undergoing Veno-Venous Extracorporeal Membrane Oxygenation Support: A Comparison between COVID-19 ARDS and ARDS from Other Etiologies. | J Clin Med | 2022 | https://conductscience.org/library/papers/35329965 | PubMed |
| 33138976 | High incidence and mortality of pneumothorax in critically Ill patients with COVID-19. | Heart Lung | 2021 | https://conductscience.org/library/papers/33138976 | PubMed |
| 25337400 | Acute respiratory distress syndrome and pneumothorax. | J Thorac Dis | 2014 | https://conductscience.org/library/papers/25337400 | PubMed |
| 17302983 | Effect of positive end-expiratory pressure and tidal volume on lung injury induced by alveolar instability. | Crit Care | 2007 | https://conductscience.org/library/papers/17302983 | PubMed |
| 17274806 | Mechanical ventilation and lung infection in the genesis of air-space enlargement. | Crit Care | 2007 | https://conductscience.org/library/papers/17274806 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8909668
GET https://conductscience.org/api/papers/v1/8909668/authors